<DOC>
	<DOCNO>NCT00415883</DOCNO>
	<brief_summary>The purpose study ass body change blood level single dose valsartan 160 mg tablet Japanese formulation valsartan 160 mg tablet global formulation fast condition healthy volunteer .</brief_summary>
	<brief_title>To Compare Blood Level Marketed Japanese Valsartan Tablet Formulation v Global Valsartan Tablet Formulation Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Valsartan</mesh_term>
	<criteria>Healthy , male female subject age 18 45 year age ( inclusive ) In good health Female subject either surgically sterilize least 6 month prior study participation postmenopausal ( regular menstrual bleeding least 2 year ) Body mass index within range 18.5 28 kg/m2 weigh least 45 kg Smokers Use prescription drug within 4 week prior dose , overthecounter medication ( vitamin , herbal supplement , dietary supplement , potassium supplement ) within 2 week prior dose . Paracetamol acceptable Participation clinical investigation within 4 week prior dose Donation loss 400 mL blood within 8 week prior first dose Significant illness within 2 week prior dose . History clinically significant cardiac abnormality , faint , low blood pressure upon stand , irregular heartbeat . History acute chronic bronchospastic disease ( include asthma chronic obstructive pulmonary disease , treat untreated ) . History clinically significant drug allergy history atopic allergy ( asthma , urticaria , eczematous dermatitis ) . Known hypersensitivity severe reaction valsartan similar drug Any surgical medical condition might significantly alter absorption , distribution , metabolism excretion drug may jeopardize subject case participation study . History immunodeficiency disease , include positive HIV ( ELISA Western blot ) test result . A positive Hepatitis B surface antigen ( HBsAg ) Hepatitis C test result . History drug alcohol abuse within 6 month prior dose Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Relative bioavailability , formulation , Japanese , valsartan , healthy subject</keyword>
</DOC>